Finance

Beta
Lists
200780:KOSDAQ
BCWorldPharm Co Ltd
₩3,595.00
-0.14%
(-5.00) 1D
Jun 12, 3:30:30 PM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 200780...
Open
₩3,605
High
₩3,740
Low
₩3,555
Mkt. cap
38.34B
Avg. vol.
20.66K
Volume
0.00
Dividend
2.53%
Quarterly dividend
₩23
Ex-dividend date
Dec 29, 2025
52-wk high
₩6,030
52-wk low
₩3,205
EPS
-₩300
Shares outstanding
10.67M
No. of employees
280
Open
₩3,605
High
₩3,740
Low
₩3,555
Mkt. cap
38.34B
Avg. vol.
20.66K
Volume
0.00
Dividend
2.53%
Quarterly dividend
₩23
Ex-dividend date
Dec 29, 2025
52-wk high
₩6,030
52-wk low
₩3,205
EPS
-₩300
Shares outstanding
10.67M
No. of employees
280
News stories
From sources across the web
About BCWorldPharm Co Ltd
CEOHong Sung Han
Employees280
Founded1980
Headquarters-
SectorPharmaceutical industry
Websitebcwp.co.kr
Previous reportsAll values in KRW
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in KRW
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
20.44B
19.25B
20.28B
19.83B
Cost of goods sold
11.71B
12.14B
12.23B
11.84B
Cost of revenue
11.71B
12.14B
12.23B
11.84B
Research and development expenses
2.39B
2.42B
2.21B
2.01B
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4.23B
4.12B
4.77B
3.87B
Operating expense
6.91B
6.96B
7.34B
6.18B
Total operating expenses
18.62B
19.10B
19.56B
18.03B
Operating income
1.82B
147.54M
719.12M
1.81B
Other non operating income
-517.86M
93.01M
654.86M
80.68M
EBT including unusual items
95.25M
-834.62M
346.56M
939.45M
EBT excluding unusual items
203.17M
-743.67M
372.30M
959.26M
Income tax expense
312.37M
146.11M
415.72M
153.81M
Effective tax rate
327.94%
-17.51%
119.96%
16.37%
Other operating expenses
74.25M
80.59M
93.16M
77.63M
Net income
-746.18M
-1.11B
-983.61M
332.94M
Net profit margin
-3.65%
-5.78%
-4.85%
1.68%
Earnings per share
-
-
-
-
Interest and investment income
27.84M
49.94M
19.53M
15.90M
Interest expense
-1.03B
-994.96M
-1.10B
-995.05M
Net interest expenses
-999.92M
-945.02M
-1.08B
-979.15M
Depreciation and amortization charges
132.65M
132.65M
137.56M
142.11M
EBITDA
3.79B
2.13B
2.76B
3.88B
Gain or loss from assets sale
101.86M
1.00K
2.61M
41.53K
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer